Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Manag Res ; 16: 347-359, 2024.
Article in English | MEDLINE | ID: mdl-38707745

ABSTRACT

Baihe Gujin decoction is one of the most commonly used decoction in traditional Chinese medicine for the treatment of lung cancer. It can nourish yin and moisten the lung as well as prevent phlegm from forming and stop coughing. On the one hand, Baihe Gujin decoction is characterized with extensive application, proven efficacy, a long history, and high safety. On the other hand, Baihe Gujin decoction can induce apoptosis of tumor cells, improve immune function and inhibit inflammation. The main anti-tumor components of this include kaempferol, quercetin, isorhamnetin, glycyrrhizin and ß-sitosterol. Clinically, Baihe Gujin decoction can improve the adverse reactions caused by radiotherapy, chemotherapy and immunotherapy for lung cancer, enhance the quality of life of patients, and prolong their survival time. At present, there are a large number of clinical and basic researches on the treatment of lung cancer with Baihe Gujin decoction. In this paper, we mainly discussed the treatment of lung cancer with Baihe Gujin decoction through analyzing basic and clinical researches at home and abroad in the past 20 years. Through the discussion, we aimed to probe deeper into Baihe Gujin decoction for the treatment of lung cancer, thereby providing a broader idea for clinical diagnosis and treatment of lung cancer.

2.
J Huazhong Univ Sci Technolog Med Sci ; 34(6): 882-888, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25480585

ABSTRACT

This study investigated the effects of miRNA-155 on malignant biological characteristics of NK/T-cell lymphoma cell lines and the possible mechanism. The expression of miRNA-155 was detected in lymphoma cell lines from different sources (SNK-6, YTS, Jurkat and DOHH2) by real-time PCR. Lentiviral vectors (pLL3.7) that could overexpress or downexpress miRNA-155 were constructed. Recombinant lentiviral particles were prepared and purified, and their titers determined. The expression of miRNA-155 in the infected SNK-6 cells and the cell proliferation were detected by PCR and CCK-8, respectively. Flow cytometry was used to determine the apoptosis of infected SNK-6 cells. The target of miRNA155 was predicted from Targetscan website. The effect of miRNA155 on FOXO3a expression was examined by Western blotting. The results showed that among the human NK/T-cell lymphoma cell lines SNK-6, YTS, Jurkat and DOHH2, the expression of miRNA-155 was highest in SNK-6. The infection efficiency of the recombinant lentivirus in SNK-6 was more than 70% at multiplicity of infection (MOI) of 100. The expression of miRNA-155 was significantly increased in SNK-6 cells infected by lentivirus vectors with high expression of miRNA-155 (4 times higher than the control group), and profoundly decreased in those infected with lentiviruses with low expression of miRNA-155. The proliferation of letivirus-infected SNK-6 cells was decreased as the expression of miRNA-155 reduced. The apoptosis rate was increased with the reduction in the expression of miRNA-155. FOXO3a was found to be a possible target of miRNA155, as suggested by Targetscan website. Western blotting showed that the expression of FOXO3a was significantly elevated in SNK-6 cells with miRNA-155 inhibition. It was concluded that reduction in miRNA-155 expression can inhibit the proliferation of SNK-6 lymphoma cells and promote their apoptosis, which may be associated with regulation of FOXO3a gene.


Subject(s)
Forkhead Transcription Factors/metabolism , Gene Expression Regulation, Neoplastic , Lymphoma, T-Cell/metabolism , MicroRNAs/biosynthesis , Natural Killer T-Cells/metabolism , Neoplasm Proteins/metabolism , RNA, Neoplasm/biosynthesis , Apoptosis/genetics , Forkhead Box Protein O3 , Forkhead Transcription Factors/genetics , Humans , Jurkat Cells , Lymphoma, T-Cell/genetics , Lymphoma, T-Cell/pathology , MicroRNAs/genetics , Natural Killer T-Cells/pathology , Neoplasm Proteins/genetics , RNA, Neoplasm/genetics , Transduction, Genetic
3.
Chin Med J (Engl) ; 125(15): 2764-7, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22931989

ABSTRACT

In this report, we present two cases of bronchial foreign body granulomas caused by the suture ties used in bronchial surgery for esophageal cancer. Both of them was hospitalized as "tumor transfer or an invasion", but pathological examination of the neoplasms indicated an inflammatory granuloma showing reaction to the foreign body. These two cases give us an attention that the neoplasms in tracheal or bronchial was not only the invasion or transfer of the primary tumor, but also the possibility of granuloma development due to the surgical sutures.


Subject(s)
Bronchial Neoplasms/etiology , Esophageal Neoplasms/surgery , Granuloma, Foreign-Body/etiology , Sutures/adverse effects , Humans , Male , Middle Aged , Postoperative Complications
4.
Biochem Biophys Res Commun ; 327(2): 393-8, 2005 Feb 11.
Article in English | MEDLINE | ID: mdl-15629128

ABSTRACT

Transforming growth factor-beta1 (TGF-beta1) is a key factor in a variety of physiological and pathological processes. Vascular endothelial growth factor (VEGF) is a key angiogenic factor, and vascular change is one of the features of airway remodeling. We examined the effect of TGF-beta1 on VEGF production by fibroblasts from mice lacking expression of Smad2 or Smad3 as well as human lung fibroblasts treated with or without Smad2 or Smad3 siRNA. TGF-beta1 stimulated VEGF production by fibroblasts from Smad2 deficient animals and wildtype animals. In contrast, TGF-beta1 did not affect VEGF production by fibroblasts from Samd3 deficient mice. Similarly, TGF-beta1 failed to stimulate VEGF production by HFL-1 cells treated with Samd3 siRNA but significantly increased VEGF production by the cells treated with Smad2 siRNA. These result suggest that TGF-beta1 stimulation of VEGF production by fibroblasts is regulated by Smad3 but not by Smad2 signaling.


Subject(s)
DNA-Binding Proteins/metabolism , Fibroblasts/drug effects , Lung/drug effects , Trans-Activators/metabolism , Transforming Growth Factor beta/pharmacology , Vascular Endothelial Growth Factor A/biosynthesis , Animals , Base Sequence , Cell Line , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/genetics , Fibroblasts/metabolism , Humans , Lung/cytology , Lung/metabolism , Mice , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Smad2 Protein , Smad3 Protein , Trans-Activators/chemistry , Trans-Activators/genetics , Transforming Growth Factor beta1 , Vascular Endothelial Growth Factor A/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...